Clinical Report: Investigating Gaps in Patient Involvement for CVD in Italy
Overview
This qualitative study highlights significant gaps in patient engagement across the cardiovascular care pathway for individuals at very high risk in Italy. Key findings indicate that emotional disruption, communication quality, and continuity of care are critical factors influencing patient involvement.
Background
Cardiovascular diseases (CVD) are the leading cause of mortality and disability globally, with Italy facing a high burden of these conditions. Effective management of CVD requires not only clinical interventions but also active patient engagement, which is essential for improving long-term outcomes. Understanding the dynamics of patient involvement can inform strategies to enhance care delivery and patient experiences.
Data Highlights
No numerical data presented in the article.
Key Findings
Patient engagement is a dynamic process influenced by emotional disruption and communication quality.
The transition from hospital to home is particularly fragile, marked by insufficient guidance and psychological support.
Participants reported territorial disparities in access to specialist care and rehabilitation services.
Inadequate doctor-patient communication and limited psychosocial support were common concerns.
Caregiver burden was highlighted as a significant factor affecting patient engagement.
Clinical Implications
Healthcare providers should prioritize strengthening discharge preparation and follow-up continuity to enhance patient engagement. Additionally, addressing psychosocial support needs and ensuring equitable access to rehabilitation services are crucial for sustaining patient involvement in their care.
Conclusion
The study underscores the importance of co-producing patient engagement through individual, relational, and organizational factors. Future research should focus on longitudinal engagement trajectories and incorporate caregiver perspectives.
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.